Angelo Maffei

Angelo Maffei

Auto-generated profile, based on publicly available information

Angelo Maffei

Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli (IS), Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2004 in Cell
Verified
Journal Article
Closed access
EPEnrico Patrucco
Enrico Patrucco
ANAntonella Notte
Antonella Notte
LBLaura Barberis
Laura Barberis
GSGiulio Selvetella
Giulio Selvetella
AMAngelo Maffei
Angelo Maffei
EHEmilio Hirsch
Emilio Hirsch

1 January 2002 in Diabetes
Verified
Journal Article
Closed access
PDF file
CVCarmine Vecchione
Carmine Vecchione
AMAngelo Maffei
Angelo Maffei
SCSalvatore Colella
Salvatore Colella
AAAlessandra Aretini
Alessandra Aretini
RPRoberta Poulet
Roberta Poulet
GLGiuseppe Lembo
Giuseppe Lembo
Recent evidence suggests that besides its action on the central nervous system, leptin can modulate vascular tone through local mechanisms involving nitric oxide (NO) release. In this study, using a fluorescent probe for direct determination of NO, we demonstrated both in endothelial cells and in vessels that leptin is able to stimulate NO release. The effect of leptin on NO is abolished by erbstatin A, a Ca2+-independent tyrosine kinase inhibitor, whereas it is not influenced by calcium removal or by other protein phosphorylation inhibitors, such as genistein (an ATP-dependent tyrosine-kinase inhibitor) or wortmannin and LY294002 (two different phosphatidylinositol [PI] 3-kinase inhibitors). Accordingly, leptin-induced vasorelaxation in aortic rings was abolished only by erbstatin A. Furthermore, immunoblotting studies revealed that leptin evokes Akt phosphorylation, with a comparable time course in both endothelial cells and vessels. Also in this experimental system, the effect of leptin was abolished by erbstatin A and not by other inhibitors. Finally, a considerable increase in endothelial NO synthase (eNOS) phosphorylation in Ser1177 was found when vessels were treated with leptin. In conclusion, leptin induces NO production by activating a PI 3-kinase–independent Akt-eNOS phosphorylation pathway.

1 March 2006 in Cell
Verified
Journal Article
Closed access
LZLuca Zacchigna
Luca Zacchigna
CVCarmine Vecchione
Carmine Vecchione
ANAntonella Notte
Antonella Notte
MCMichelangelo Cordenonsi
Michelangelo Cordenonsi
SDSirio Dupont
Sirio Dupont
GBGiorgio M. Bressan
Giorgio M. Bressan

11 April 2005 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CVCarmine Vecchione
Carmine Vecchione
EPEnrico Patrucco
Enrico Patrucco
GMGennaro Marino
Gennaro Marino
LBLaura Barberis
Laura Barberis
RPRoberta Poulet
Roberta Poulet
GLGiuseppe Lembo
Giuseppe Lembo
Hypertension affects nearly 20% of the population in Western countries and strongly increases the risk for cardiovascular diseases. In the pathogenesis of hypertension, the vasoactive peptide of the renin-angiotensin system, angiotensin II and its G protein–coupled receptors (GPCRs), play a crucial role by eliciting reactive oxygen species (ROS) and mediating vessel contractility. Here we show that mice lacking the GPCR-activated phosphoinositide 3-kinase (PI3K)γ are protected from hypertension that is induced by administration of angiotensin II in vivo. PI3Kγ was found to play a role in angiotensin II–evoked smooth muscle contraction in two crucial, distinct signaling pathways. In response to angiotensin II, PI3Kγ was required for the activation of Rac and the subsequent triggering of ROS production. Conversely, PI3Kγ was necessary to activate protein kinase B/Akt, which, in turn, enhanced L-type Ca2+ channel–mediated extracellular Ca2+ entry. These data indicate that PI3Kγ is a key transducer of the intracellular signals that are evoked by angiotensin II and suggest that blocking PI3Kγ function might be exploited to improve therapeutic intervention on hypertension.

1 February 2009 in Neurobiology of Aging
Verified
Journal Article
Closed access
MGMaria Teresa Gentile
Maria Teresa Gentile
RPRoberta Poulet
Roberta Poulet
APAlba Di Pardo
Alba Di Pardo
GCGiuseppe Cifelli
Giuseppe Cifelli
AMAngelo Maffei
Angelo Maffei
GLGiuseppe Lembo
Giuseppe Lembo

1 April 2005 in American Journal of Hypertension
Verified
Journal Article
Closed access
FCF Cosentino
F Cosentino
CSCarmine Savoia
Carmine Savoia
PDP Depaolis
P Depaolis
PFP Francia
P Francia
ARA Russo
A Russo
MVMassimo Volpe
Massimo Volpe
Vasoconstrictive, proliferative and oxidative effects of angiotensin II (Ang II) are mediated by Ang II type 1 (AT1) receptors. The effects of Ang II via the Ang II type 2 (AT2) receptor subtype (AT2R) are less well defined. Growing evidence shows the existence of cross-talk between the Ang II receptor subtypes, which is revealed by AT1R blockade. Hence, under certain conditions, AT2R may act as an antagonistic system with respect to the AT1R. The present study was designed to investigate the effects of long-term treatment with the AT1R antagonist losartan on the AT2R-mediated response to Ang II in thoracic aortas isolated from spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. Untreated animals from both groups were used as controls. The mRNA expression of AT1R and AT2R was measured by reverse transcription-polymerase chain reaction. During contraction in response to norepinephrine, Ang II induced concentration-dependent relaxation only in aortas isolated from SHR chronically treated with losartan (8 weeks; 30 mg/kg/day in drinking water). These relaxations were inhibited by the selective AT2R blocker PD123319, N(G)-nitro-L-arginine methyl ester (L-NAME), and B2receptor antagonist HOE-140. Accordingly, nitric oxide (NO) production was increased by Ang II only in the aortas of treated SHR. After AT1R blockade, AT2R mRNA was significantly increased. These findings demonstrate that, in hypertensive rats, chronic AT1R blockade is associated with an inverted vasomotor response to Ang II via AT2R-mediated NO production. The losartan-unmasked AT2R-vasorelaxation could significantly contribute to the beneficial hemodynamic effects of AT1R blockade. In view of this, our study highlights the importance of the integrated Ang II receptor network, which may help to define further the mechanisms of the well-established vascular protective effects of AT1R blockers.